<?xml version="1.0" encoding="UTF-8"?>
<p>A pyrimidine synthesis inhibitor such as NITD008 exhibited antiviral activity against ZIKV in vitro (EC
 <sub>50</sub> = 0.28–0.95 µM) and in A129 mice treated with 50 mg/kg/day of the drug. Also, 50% of NITD008-treated mice survived without developing any neurological signs [
 <xref rid="B54-pharmaceuticals-12-00101" ref-type="bibr">54</xref>]. However, due to toxic effects in pre-clinical evaluation, this drug was dismissed [
 <xref rid="B55-pharmaceuticals-12-00101" ref-type="bibr">55</xref>]. 
</p>
